InvestorsHub Logo
Followers 6
Posts 121
Boards Moderated 0
Alias Born 09/05/2023

Re: None

Tuesday, 11/28/2023 5:02:23 AM

Tuesday, November 28, 2023 5:02:23 AM

Post# of 461750
Nothing in today's CC changes the fact that Rett and Alzheimer are moving towards approval. The delay in the Rett was due to a CRO being late on data safety submission. It is still the same company, with late-stage RETT and Alzheimer moving towards approval and the same drug, A2-73 Blarcamesine, that has never failed a trial, and there have been multiple trials on both Rett and Alzheimer. Nothing has changed other than waiting on one of the Rett CROs. The drop in SP was an overreaction because nothing changed the value of the company. The stock market does not operate on logic for the most part.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News